文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹

银屑病生物制剂治疗中出现矛盾性湿疹的血单细胞转录组与蛋白质组特征

Blood Single-Cell Transcriptomic and Proteomic Signatures of Paradoxical Eczema in Patients with Psoriasis Treated with Biologics.
PubMed 文献 · J Invest Dermatol · 2025-03-27

本研究针对银屑病患者使用生物制剂后出现的矛盾性湿疹,采用单细胞RNA测序和质谱流式技术,发现病例细胞簇中TNF、IFN-γ、IFN-α及其信号通路表达增加,且影响趋化因子和TNF通路基因表达的遗传变异与矛盾性湿疹相关,独立于已知特应性风险位点。

要点

  • 矛盾性湿疹呈现以1型为主的系统性炎症特征。
  • TNF、IFN-γ、IFN-α信号通路在矛盾性湿疹中表达增加。
  • 趋化因子和TNF通路基因的遗传易感性可能促进该表型。

核心结论

  • 矛盾性湿疹具有以1型为主的系统性炎症特征,遗传易感性涉及趋化因子和TNF通路信号异常。

研究设计与样本

  • 采用单细胞RNA测序和质谱流式技术比较矛盾性湿疹病例与匹配的银屑病对照。
  • 在独立基因分型队列中分析遗传变异与矛盾性湿疹的关联。

主要发现

  • 矛盾性湿疹病例细胞簇中TNF、IFN-γ、IFN-α及其信号通路表达增加。
  • 影响趋化因子信号和TNF通路基因表达的遗传变异与矛盾性湿疹相关,且独立于已知特应性风险位点。

临床怎么用

  • 提示矛盾性湿疹的1型炎症特征可能为临床识别和靶向干预提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Biologics targeting the TNF and IL-17/23 axis are highly effective treatments for psoriasis but can result in cutaneous adverse events. The pathogenesis of paradoxical eczema, the occurrence of an atopic dermatitis phenotype after biologic initiation in people with psoriasis, is unknown. Using single-cell RNA sequencing and mass cytometry, we found increased expression of TNF, IFN-γ, and IFN-α and their signaling pathways in paradoxical eczema case cell clusters compared with that in matched psoriasis controls. Genetic variants influencing the expression of chemokine signaling and TNF pathway genes were associated with paradoxical eczema in a separate genotyped cohort, and this association was independent of known atopic risk loci. This suggests that paradoxical eczema has a predominantly type 1 systemic inflammatory signature and that genetic susceptibility to aberrant chemokine and TNF pathway signaling could contribute to development of this phenotype during biologic treatment.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Al-Janabi A, Martin P, Simpson C, et al. Blood Single-Cell Transcriptomic and Proteomic Signatures of Paradoxical Eczema in Patients with Psoriasis Treated with Biologics. J Invest Dermatol. 2025. PMID: 40157420. doi:10.1016/j.jid.2025.02.153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。